Press release
What are the Factors Influencing Growth in the Human Umbilical Vein Endothelial Cells (HUVEC) Market ?
Award-winning consulting firm Fact.MR’s report on the global human umbilical vein endothelial cells (HUVEC) market forecasts a healthy growth trajectory for the 2021-2031 forecast period. According to the study, rapid advancements in biotechnology and genetic engineering are opening up new growth avenues for advanced disease treatment, particularly across areas such as oncology.As per data published by GLOBOCAN, global cancer burden rose to 19.3 million cases, while associated fatalities increased to 10 million by 2020. Amongst all the cancers, breast cancer accounts for nearly a quarter of the total cases diagnosed every year. Hence, healthcare providers are incorporating highly advanced therapeutic approaches, thereby widening the growth prospects for human umbilical vein endothelial cells.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6216
Manufacturers are directing bulk of their investments across key regions such as China, India, and other countries in Asia Pacific. Over the years, these countries have witnessed unprecedented expansion of their existing healthcare infrastructure. This is majorly attributed to the presence of a huge population base, necessitating delivery of advanced healthcare for various chronic and infectious diseases.
Key Takeaways from Market Study
• By type, pooled donor-derived HUVECs are expected to experience elevated sales through 2031
• Oncology to emerge as a highly promising application area for HUVEC-based treatment
• The U.S. to generate multiple revenue streams for the market, across CVD treatment, oncology, and angiogenesis
• Extensive development of biotechnology and cell culture studies driving demand across India
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6216
Competitive Landscape
Prominent HUVEC providers as profiled by Fact.MR include Lonza Group AG, PromoCell- Human Centered Science, Merck & Co. KGaA, Thermo Fisher Scientific, Lifeline, and Corning Inc. Due to the presence of such a handful of service providers, the market appears highly consolidated.
In May 2021, Merck & Co. announced 40 abstracts, seven oral presentations and seven poster discussions from company and investigator sponsored studies and external collaborations for its oncology treatment furtherance, an initiative which will likely provide tailwinds to its HUVEC portfolio.
In January 2021, PromoCell received the EXCiPACTTM certification scheme for pharmaceutical excipients to Good Manufacturing Practice (GMP) standards, which implied that the company can provide tailor-made cell culture media and reagents based on each client’s end user requirements.
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the human umbilical vein endothelial cells market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (single donors and pooled donors) and application (wound healing, angiogenesis, tissue engineering, inflammation, oncology, and others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).
For in-depth competitive analysis, buy now –
https://www.factmr.com/checkout/6216
Human Umbilical Vein Endothelial Cells (HUVEC) Market - Scope of Report
A recent study by Fact.MR on the human umbilical vein endothelial cells (HUVEC) market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering human umbilical vein endothelial cells.
The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the HUVEC market, along with their product portfolios, enhances the reliability of this comprehensive research study.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6216
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What are the Factors Influencing Growth in the Human Umbilical Vein Endothelial Cells (HUVEC) Market ? here
News-ID: 2297963 • Views: …
More Releases from Fact.MR
Eye Care Services Market Outlook 2025-2035: Key Developments and Future Scope
The global eye care services market is poised for steady expansion through 2035 as demographic shifts, rising prevalence of refractive and retinal disorders, technological advances, and broader access to care combine to increase demand for comprehensive vision services. From routine vision screening and optical dispensing to advanced diagnostics, cataract and refractive surgeries, and retinal interventions, the market is evolving into an integrated continuum of screening, diagnosis, treatment, and post-operative care.…
Electric Boat Market Outlook 2025-2035: Innovation, Growth, and Demand Trends
The electric boat market is entering a period of accelerated growth as advances in battery and propulsion technology, rising fuel prices, tightening emissions regulations, and shifting consumer preferences for quieter, lower-maintenance vessels converge. From recreational leisure craft and ferries to workboats and short-route passenger vessels, electrification is reshaping marine propulsion - enabling operators to lower operating costs, reduce local pollution, and offer new, experience-driven services in tourism, urban water transport,…
European Breathable Films Market Forecast 2025-2035: Trends and Growth Insights
The breathable films market is set for steady growth over the 2025-2035 period as rising demand across hygiene, medical, packaging, and technical textile applications drives adoption of film technologies that combine moisture vapor transmission with liquid barrier performance. Innovations in polymer science, micro- and macro-porous structures, and multi-layer extrusion are enabling films that deliver both comfort and protection, expanding use in products such as diapers, surgical drapes, wound care dressings,…
European Beer Market Outlook 2025-2035: Innovation, Growth, and Demand Trends
The global beer market is positioned for steady, mature growth through 2035 as shifting consumer preferences, premiumization trends, evolving production technologies, and expanding on-trade and off-trade channels shape demand. While traditional mass-lager consumption remains substantial, growth is increasingly driven by craft, premium, and specialty variants, along with innovation in low- and no-alcohol formulations. Regional dynamics are evolving as Asia-Pacific and select emerging markets sustain volume growth, while North America and…
More Releases for HUVEC
Human Platelet Lysate Market Expanding at a CAGR of 6.5% by 2035 | Asia Pacific, …
The global human platelet lysate market is projected to grow from approximately USD 160.0 million in 2025 to around USD 300.0 million by 2035, representing a compound annual growth rate (CAGR) of about 6.5% over the forecast period.
Growth is underpinned by increasing adoption of cell therapy solutions, rising demand for xeno-free cell culture media, and expanding applications in regenerative medicine and biotechnology research.
Human platelet lysate (HPL) serves as a high-performance…
Human Umbilical Vein Endothelial Cells (HUVEC) Market Is Set To Register A CAGR …
The market for Human Umbilical Vein Endothelial Cells (HUVEC) is a vital segment within the field of cell culture and regenerative medicine. HUVECs, as primary cells, are widely used in various biomedical and pharmaceutical research applications, making them integral in understanding vascular biology, angiogenesis, and drug development. This market overview will provide insights into the current state of the HUVEC market, recent developments, and key factors influencing its growth.
Growth of…
Human Umbilical Vein Endothelial Cells (HUVEC) Market 2028- Analysis And In-Dept …
QY Research has recently published a new report, titled Global Human Umbilical Vein Endothelial Cells (HUVEC) Market Research Report 2022. The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Umbilical Vein Endothelial Cells (HUVEC) market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the…
Human Umbilical Vein Endothelial Cells (HUVEC) Market Will Continue to Boom in t …
The Human Umbilical Vein Endothelial Cells (HUVEC) Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore, based on input from industry experts, the report provides actionable insights into the Human Umbilical Vein Endothelial Cells (HUVEC) market's future growth to…
Cosmetic Peptide Synthesis Market is projected to expand at a CAGR of 10.7% over …
Growing significance of genomics and proteomics has been contributing to the growth of the global vascular endothelial growth factor (VEGF) market. The market was valued at US$ 195.4 Mn at the end of 2021 and is projected to expand at a CAGR of 10.7% over the forecast period (2022-2032), according to Persistence Market Research.
Tumor cells, keratinocytes, platelets, renal mesangial cells, and macrophages are among the cells that produce VEGF. VEGF's…
Endothelial Cells Latest Trends and Forecast Analysis up to 2031
250 Pages Endothelial Cells Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
Subtitle –Fact MR analysis of Endothelial Cells market provides compelling insights into the factors propelling sales prospects in key segments. It provides an executive-level blueprint of key market players' strategies and analyses their impact on overall growth projections.
According to Fact MR’s recent market research, Endothelial Cells sales to swell at propelled CAGR through 2031, as…
